These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 27492023)

  • 1. Nanoparticle-mediated siRNA delivery assessed in a 3D co-culture model simulating prostate cancer bone metastasis.
    Fitzgerald KA; Guo J; Raftery RM; Castaño IM; Curtin CM; Gooding M; Darcy R; O' Brien FJ; O' Driscoll CM
    Int J Pharm; 2016 Sep; 511(2):1058-69. PubMed ID: 27492023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of collagen-based scaffolds to simulate prostate cancer bone metastases with potential for evaluating delivery of nanoparticulate gene therapeutics.
    Fitzgerald KA; Guo J; Tierney EG; Curtin CM; Malhotra M; Darcy R; O'Brien FJ; O'Driscoll CM
    Biomaterials; 2015 Oct; 66():53-66. PubMed ID: 26196533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and Evaluation of Anisamide-Targeted Amphiphilic Cyclodextrin Nanoparticles To Promote Therapeutic Gene Silencing in a 3D Prostate Cancer Bone Metastases Model.
    Evans JC; Malhotra M; Fitzgerald KA; Guo J; Cronin MF; Curtin CM; O'Brien FJ; Darcy R; O'Driscoll CM
    Mol Pharm; 2017 Jan; 14(1):42-52. PubMed ID: 28043128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paracrine interactions between LNCaP prostate cancer cells and bioengineered bone in 3D in vitro culture reflect molecular changes during bone metastasis.
    Sieh S; Taubenberger AV; Lehman ML; Clements JA; Nelson CC; Hutmacher DW
    Bone; 2014 Jun; 63():121-31. PubMed ID: 24530694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 3D in vitro model of patient-derived prostate cancer xenograft for controlled interrogation of in vivo tumor-stromal interactions.
    Fong EL; Wan X; Yang J; Morgado M; Mikos AG; Harrington DA; Navone NM; Farach-Carson MC
    Biomaterials; 2016 Jan; 77():164-72. PubMed ID: 26599623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel, anisamide-targeted cyclodextrin nanoformulation for siRNA delivery to prostate cancer cells expressing the sigma-1 receptor.
    Fitzgerald KA; Malhotra M; Gooding M; Sallas F; Evans JC; Darcy R; O'Driscoll CM
    Int J Pharm; 2016 Feb; 499(1-2):131-145. PubMed ID: 26721726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growth.
    Liu XQ; Xiong MH; Shu XT; Tang RZ; Wang J
    Mol Pharm; 2012 Oct; 9(10):2863-74. PubMed ID: 22924580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient delivery of micro RNA to bone-metastatic prostate tumors by using aptamer-conjugated atelocollagen in vitro and in vivo.
    Hao Z; Fan W; Hao J; Wu X; Zeng GQ; Zhang LJ; Nie SF; Wang XD
    Drug Deliv; 2016; 23(3):874-81. PubMed ID: 24892627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain tumor-targeted therapy by systemic delivery of siRNA with Transferrin receptor-mediated core-shell nanoparticles.
    Wei L; Guo XY; Yang T; Yu MZ; Chen DW; Wang JC
    Int J Pharm; 2016 Aug; 510(1):394-405. PubMed ID: 27374198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic implications of enhanced G(0)/G(1) checkpoint control induced by coculture of prostate cancer cells with osteoblasts.
    Pinski J; Parikh A; Bova GS; Isaacs JT
    Cancer Res; 2001 Sep; 61(17):6372-6. PubMed ID: 11522628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of prostate cancer cell migration toward bone marrow stromal cell-conditioned medium by Wnt5a signaling.
    Jin F; Qu X; Fan Q; Wang L; Tang T; Hao Y; Dai K
    Mol Med Rep; 2013 Nov; 8(5):1486-92. PubMed ID: 24064566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan (CMD)-mediated co-delivery of SN38 and Snail-specific siRNA as a useful anticancer approach against prostate cancer.
    Afkham A; Aghebati-Maleki L; Siahmansouri H; Sadreddini S; Ahmadi M; Dolati S; Afkham NM; Akbarzadeh P; Jadidi-Niaragh F; Younesi V; Yousefi M
    Pharmacol Rep; 2018 Jun; 70(3):418-425. PubMed ID: 29626645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-air production of 3D co-culture tumor spheroid hydrogels for expedited drug screening.
    Antunes J; Gaspar VM; Ferreira L; Monteiro M; Henrique R; Jerónimo C; Mano JF
    Acta Biomater; 2019 Aug; 94():392-409. PubMed ID: 31200118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discoidin domain receptor 2 facilitates prostate cancer bone metastasis via regulating parathyroid hormone-related protein.
    Yan Z; Jin S; Wei Z; Huilian H; Zhanhai Y; Yue T; Juan L; Jing L; Libo Y; Xu L
    Biochim Biophys Acta; 2014 Sep; 1842(9):1350-63. PubMed ID: 24787381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using high throughput microtissue culture to study the difference in prostate cancer cell behavior and drug response in 2D and 3D co-cultures.
    Mosaad E; Chambers K; Futrega K; Clements J; Doran MR
    BMC Cancer; 2018 May; 18(1):592. PubMed ID: 29793440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Target specific delivery of anticancer drug in silk fibroin based 3D distribution model of bone-breast cancer cells.
    Subia B; Dey T; Sharma S; Kundu SC
    ACS Appl Mater Interfaces; 2015 Feb; 7(4):2269-79. PubMed ID: 25557227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D Porous Chitosan-Alginate Scaffolds as an In Vitro Model for Evaluating Nanoparticle-Mediated Tumor Targeting and Gene Delivery to Prostate Cancer.
    Wang K; Kievit FM; Florczyk SJ; Stephen ZR; Zhang M
    Biomacromolecules; 2015 Oct; 16(10):3362-72. PubMed ID: 26347946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclodextrin mediated delivery of NF-κB and SRF siRNA reduces the invasion potential of prostate cancer cells in vitro.
    Evans JC; McCarthy J; Torres-Fuentes C; Cryan JF; Ogier J; Darcy R; Watson RW; O'Driscoll CM
    Gene Ther; 2015 Oct; 22(10):802-10. PubMed ID: 26005860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anisamide-targeted cyclodextrin nanoparticles for siRNA delivery to prostate tumours in mice.
    Guo J; Ogier JR; Desgranges S; Darcy R; O'Driscoll C
    Biomaterials; 2012 Nov; 33(31):7775-84. PubMed ID: 22828585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
    Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
    Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.